New Research Indicates Treating Neonatal Respiratory Distress Syndrome with CUROSURF® Results in Lower Rate of Mortality Compared to Competitive Surfactants
First of Its Kind Retrospective Comparison in More than 14,000Premature Infants Published in the Journal ofPerinatologyCARY, N.C.–(BUSINESS WIRE)–Sep 12, 2011 – CornerstoneTherapeutics (NASDAQ: CRTX), a specialty pharmaceutical…
September 13th, 2011
Posted in
Drug